Molecular Neurodegeneration

Molecular Neurodegeneration

分子神经变性

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Molecular Neurodegeneration》是由BioMed Central出版社于2006年创办的英文国际期刊(ISSN: 1750-1326,E-ISSN: 1750-1326),该期刊长期致力于神经科学领域的创新研究,主要研究方向为医学-神经科学。作为SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA开放获取模式(OA占比1%),以发表神经科学领域等方向的原创性研究为核心(研究类文章占比65.38%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在78篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Molecular Neurodegeneration审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约78篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 78 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
NEUROSCIENCES 神经科学
1区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
1区
NEUROSCIENCES 神经科学
1区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:NEUROSCIENCES SCIE Q1 8 / 310

97.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:NEUROSCIENCES SCIE Q1 8 / 310

97.58%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:23 SJR:5.205 SNIP:2.566
学科类别 分区 排名 百分位
大类:Medicine 小类:Neurology (clinical) Q1 6 / 400

98%

大类:Medicine 小类:Cellular and Molecular Neuroscience Q1 3 / 97

97%

大类:Medicine 小类:Molecular Biology Q1 15 / 410

96%

期刊发文

  • Leveraging the glymphatic and meningeal lymphatic systems as therapeutic strategies in Alzheimer's disease: an updated overview of nonpharmacological therapies

    Author: Formolo, Douglas A. A.; Yu, Jiasui; Lin, Kangguang; Tsang, Hector W. H.; Ou, Haining; Kranz, Georg S. S.; Yau, Suk-Yu

    Journal: MOLECULAR NEURODEGENERATION. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13024-023-00618-3

  • Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

    Author: Xiong, Monica; Wang, Chao; Gratuze, Maud; Saadi, Fareeha; Bao, Xin; Bosch, Megan E.; Lee, Choonghee; Jiang, Hong; Serrano, Javier Remolina; Gonzales, Ernesto R.; Kipnis, Michal; Holtzman, David M.

    Journal: MOLECULAR NEURODEGENERATION. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13024-023-00610-x

  • Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications

    Author: Gonzalez-Ortiz, Fernando; Kac, Przemyslaw R.; Brum, Wagner S.; Zetterberg, Henrik; Blennow, Kaj; Karikari, Thomas K.

    Journal: MOLECULAR NEURODEGENERATION. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13024-023-00605-8

  • Cerebrospinal fluid lipoproteins inhibit alpha-synuclein aggregation by interacting with oligomeric species in seed amplification assays

    Author: Bellomo, Giovanni; Paciotti, Silvia; Concha-Marambio, Luis; Rizzo, Domenico; Wojdala, Anna Lidia; Chiasserini, Davide; Gatticchi, Leonardo; Cerofolini, Linda; Giuntini, Stefano; De Luca, Chiara Maria Giulia; Ma, Yihua; Farris, Carly M.; Pieraccini, Giuseppe; Bologna, Sara; Filidei, Marta; Ravera, Enrico; Lelli, Moreno; Moda, Fabio; Fragai, Marco; Parnetti, Lucilla; Luchinat, Claudio

    Journal: MOLECULAR NEURODEGENERATION. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13024-023-00613-8

  • Targeting a vulnerable septum-hippocampus cholinergic circuit in a critical time window ameliorates tau-impaired memory consolidation

    Author: Wu, Dongqin; Yu, Nana; Gao, Yang; Xiong, Rui; Liu, Luping; Lei, Huiyang; Jin, Sen; Liu, Jiale; Liu, Yingzhou; Xie, Jiazhao; Liu, Enjie; Zhou, Qiuzhi; Liu, Yanchao; Li, Shihong; Wei, Linyu; Lv, Jingru; Yu, Huilin; Zeng, Wenbo; Zhou, Qiang; Xu, Fuqiang; Luo, Min-Hua; Zhang, Yao; Yang, Ying; Wang, Jian-Zhi

    Journal: MOLECULAR NEURODEGENERATION. 2023; Vol. 18, Issue 1, pp. -. DOI: 10.1186/s13024-023-00614-7

  • Differences in neurotropism and neurotoxicity among retrograde viral tracers

    Author: Leqiang Sun, Yajie Tang, Keji Yan, Jinsong Yu, Yanyan Zou, Weize Xu, Ke Xiao, Zhihui Zhang, Weiming Li, Beili Wu, Zhe Hu, Kening Chen, Zhen F. Fu, Jinxia Dai, Gang Cao

    Journal: Molecular Neurodegeneration, 2019, Vol.14, , DOI:10.1186/s13024-019-0308-6

  • Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease

    Author: Yaping Shao, Weidong Le

    Journal: Molecular Neurodegeneration, 2019, Vol.14, , DOI:10.1186/s13024-018-0304-2

  • Advances in developing novel therapeutic strategies for Alzheimer’s disease

    Author: Jiqing Cao, Jianwei Hou, Jing Ping, Dongming Cai

    Journal: Molecular Neurodegeneration, 2018, Vol.13, , DOI:10.1186/s13024-018-0299-8